MindMed CMO to Chair Digital Biomarkers Summit Post published:October 25, 2021 Post category:Press Release
MindMed Joins Clinical Trials Transformation Initiative Post published:October 13, 2021 Post category:Press Release
MindMed Announces Strategic Research Collaboration with Sphere Health Post published:October 5, 2021 Post category:Press Release
MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors and Transition of Bruce Linton Post published:September 30, 2021 Post category:Press Release
MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory Board Post published:September 29, 2021 Post category:Press Release
MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration Post published:September 23, 2021 Post category:Press Release
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes Post published:September 2, 2021 Post category:Press Release
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders Post published:August 24, 2021 Post category:Press Release
MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium Post published:August 17, 2021 Post category:Press Release
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline Post published:August 12, 2021 Post category:Press Release